Quarterly Result28 May 2026, 10:39 pm
PRISM MEDICO Board approves Q4 & FY26 Audited Results
AI Summary
PRISM MEDICO AND PHARMACY LTD's Board of Directors, at their meeting on May 28, 2026, approved the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026. The company also confirmed that the Independent Auditor's Report for the financial year ended March 31, 2026, issued by C.A. Garg Mendiratta & Associates, contains an unmodified opinion. The audit was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board approved Audited Standalone Financial Results for Q4 and FY26.
- Results pertain to the quarter and year ended March 31, 2026.
- Auditor's Report for FY26 contains an unmodified opinion.
- Board meeting was held on May 28, 2026.
Price Impact
More from PRISMMEDI